Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.brs.2024.11.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Utility of [Tc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a feasibility study.
Cancer Immunol Immunother
September 2025
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, CHUV/UNIL, 1011, Lausanne, Switzerland.
Background: Immunotherapy is a mainstay in the treatment of patients with advanced melanoma. Yet, resistance mechanisms exist, and tumour-associated macrophages (TAMs), particularly the M2-like phenotype, are associated with poorer outcomes, with CD206 serving as their specific marker. We present the first human SPECT/CT study to visualize CD206 + TAMs in patients undergoing immunotherapy and compare the findings to clinical outcomes (NCT04663126).
View Article and Find Full Text PDFBackground: Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia primarily affecting Black women. To date, there are no standardized treatment regimens or approved medications for the treatment of CCCA. This single-center, open-label, clinical study investigated the efficacy of apremilast in the treatment of mild to moderate vertex-predominant CCCA.
View Article and Find Full Text PDFImpact of Tranexamic Acid on Postpartum Hemorrhage in Type 1 von Willebrand Disease Treated with Recombinant VWF.
Blood Adv
September 2025
University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Postpartum hemorrhage (PPH) affects up to 44% of women with von Willebrand disease (VWD) despite recombinant VWF (rVWF) treatment. As tranexamic acid (TXA) reduced PPH-related deaths in the WOMAN trial, we assessed whether TXA combined with rVWF versus rVWF alone prevents PPH in VWD. VWD-Woman, a phase 3, open-label, randomized pilot trial, enrolled pregnant women ≥18 years with VWD (VWF:RCo <0.
View Article and Find Full Text PDFTreatment of Acne Vulgaris With a Topical Application of Retinaldehyde, Glycolic Acid, and Silybum marianum Fruit Extract: A Pilot Study.
Cureus
August 2025
Dermatology, Pierre Fabre Dermocosmetics Brazil, São Paulo, BRA.
Background In acne-prone skin, the loss of homeostasis leads to aberrant epithelial differentiation, promoting the formation of microcomedones. The maintenance of sebaceous stem cell homeostasis has emerged as a new therapeutic target in acne management. Objective: The aim of this study is to evaluate the efficacy, tolerability, and safety of a topical formulation combining retinaldehyde, glycolic acid, and Silybum marianum fruit extract for the treatment of acne vulgaris.
View Article and Find Full Text PDFThe Acceptance, Commitment and COgnitive RemeDiation (ACCORD) Study: Can a Brief Online Cognitive Intervention Improve Outcomes in Patients With Esophageal Disease?
Neurogastroenterol Motil
August 2025
Division of Gastroenterology & Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Background: Cognitive and psychological inflexibility are two mental processes that influence how a person interprets and responds to esophageal symptoms. Patients with greater mental inflexibility are at risk for poorer outcomes. Brain-gut behavioral therapies (BGBT) are effective adjunctive treatments in many digestive diseases, with potential to improve mental flexibility.
View Article and Find Full Text PDF